The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Apr 2021
Randomized Controlled Trial Multicenter StudyAvelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Chemoradiotherapy is the standard of care for unresected locally advanced squamous cell carcinoma of the head and neck. We aimed to assess if addition of avelumab (anti-PD-L1) to chemoradiotherapy could improve treatment outcomes for this patient population. ⋯ Pfizer and Merck KGaA, Darmstadt, Germany.